The recombinant bacteriophage endolysin HY-133 exhibits in vitro activity against different African clonal lineages of the staphylococcus aureus complex, including staphylococcus schweitzeri

Antimicrobial Agents and Chemotherapy

Volumn 60, Issue 4, 2016, Pages 2551-2553

  Idelevich, Evgeny A ^a   Schaumburg, Frieder ^a   Knaack, Dennis ^a   Scherzinger, Anna S ^b   Mutter, Wolfgang ^b   Peters, Georg ^a   Peschel, Andreas ^c,d   Becker, Karsten ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b BIOMÉRIEUX   (France)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d German Centre for Infection Research (DZIF)   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOLYSIN HY 133; HYDROLASE; LYSOSTAPHIN; PEPTIDOGLYCAN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; CEFTAROLINE; CEFTOBIPROLE; CEPHALOSPORIN DERIVATIVE; ENDOLYSIN; PROTEINASE; RECOMBINANT PROTEIN;

AFRICA SOUTH OF THE SAHARA; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIOPHAGE; BACTERIUM ISOLATE; BROTH DILUTION; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC BACKGROUND; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS SENSU STRICTO; STAPHYLOCOCCUS SCHWEITZERI; AFRICA; BIOSYNTHESIS; DRUG EFFECTS; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PENICILLIN RESISTANCE; STAPHYLOCOCCUS INFECTION; STAPHYLOCOCCUS PHAGE;

AFRICA; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; CEPHALOSPORINS; ENDOPEPTIDASES; HUMANS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; RECOMBINANT PROTEINS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS PHAGES;

EID: 84963785986     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02859-15     Document Type: Article

References (14)

1. Schmelcher M, Donovan DM, Loessner MJ. 2012. Bacteriophage endolysins as novel antimicrobials. Future Microbiol 7:1147-1171. http://dx.doi.org/10.2217/fmb.12.97.
2. Falagas ME, Karageorgopoulos DE, Leptidis J, Korbila IP. 2013. MRSA in Africa: filling the global map of antimicrobial resistance. PLoS One 8:e68024. http://dx.doi.org/10.1371/journal.pone.0068024.
3. Idelevich EA, von Eiff C, Friedrich AW, Iannelli D, Xia G, Peters G, Peschel A, Wanninger I, Becker K. 2011. In vitro activity against Staphylococcus aureus of a novel antimicrobial agent, PRF-119, a recombinant chimeric bacteriophage endolysin. Antimicrob Agents Chemother 55:4416-4419. http://dx.doi.org/10.1128/AAC.00217-11.
4. Knaack D, Idelevich EA, Schleimer N, Scherzinger AS, Kriegeskorte A, Peters G, Mutter W, Becker K. 2015. In vitro activity of recombinant chimeric bacteriophage endolysins against Staphylococcus aureus under different growth conditions. 25th European Conference of Clinical Microbiology and Infectious Diseases. ESCMID Online Lecture Library, no. P0727.
5. Tong SY, Schaumburg F, Ellington MJ, Corander J, Pichon B, Leendertz F, Bentley SD, Parkhill J, Holt DC, Peters G, Giffard PM. 2015. Novel staphylococcal species that form part of a Staphylococcus aureus-related complex: the non-pigmented Staphylococcus argenteus sp. nov. and the non-human primate-associated Staphylococcus schweitzeri sp. nov. Int J Syst Evol Microbiol 65:15-22. http://dx.doi.org/10.1099/ijs.0.062752-0.
6. Schaumburg F, Pauly M, Anoh E, Mossoun A, Wiersma L, Schubert G, Flammen A, Alabi AS, Muyembe-Tamfum JJ, Grobusch MP, Karhemere S, Akoua-Koffi C, Couacy-Hymann E, Kremsner PG, Mellmann A, Becker K, Leendertz FH, Peters G. 2015. Staphylococcus aureus complex from animals and humans in three remote African regions. Clin Microbiol Infect 21:345. e1-345.e8. http://dx.doi.org/10.1016/j.cmi.2014.12.001.
7. Schaumburg F, Alabi AS, Peters G, Becker K. 2014. New epidemiology of Staphylococcus aureusinfectionin Africa. Clin Microbiol Infect 20:589-596. http://dx.doi.org/10.1111/1469-0691.12690.
8. Gründling A, Schneewind O. 2006. Cross-linked peptidoglycan mediates lysostaphin binding to the cell wall envelope of Staphylococcus aureus. J Bacteriol 188:2463-2472. http://dx.doi.org/10.1128/JB.188.7.2463-2472.2006.
9. Okon KO, Shittu AO, Kudi AA, Umar H, Becker K, Schaumburg F. 2014. Population dynamics of Staphylococcus aureus from northeastern Nigeria in 2007 and 2012. Epidemiol Infect 142:1737-1740. http://dx.doi.org/10.1017/S0950268813003117.
10. Schaumburg F, Ateba Ngoa U, Kösters K, Köck R, Adegnika AA, Kremsner PG, Lell B, Peters G, Mellmann A, Becker K. 2011. Virulence factors and genotypes of Staphylococcus aureus from infection and carriage in Gabon. Clin Microbiol Infect 17:1507-1513. http://dx.doi.org/10.1111/j.1469-0691.2011.03534.x.
11. Ateba Ngoa U, Schaumburg F, Adegnika AA, Kösters K, Moller T, Fernandes JF, Alabi A, Issifou S, Becker K, Grobusch MP, Kremsner PG, Lell B. 2012. Epidemiology and population structure of Staphylococcus aureus in various population groups from a rural and semi urban area in Gabon, Central Africa. Acta Trop 124:42-47. http://dx.doi.org/10.1016/j.actatropica.2012.06.005.
12. Schaumburg F, Alabi AS, Mombo-Ngoma G, Kaba H, Zoleko RM, Diop DA, Mackanga JR, Basra A, Gonzalez R, Menendez C, Grobusch MP, Kremsner PG, Köck R, Peters G, Ramharter M, Becker K. 2014. Transmission of Staphylococcus aureus between mothers and infants in an African setting. Clin Microbiol Infect 20:O390-O396. http://dx.doi.org/10.1111/1469-0691.12417.
13. Schaumburg F, Mugisha L, Peck B, Becker K, Gillespie TR, Peters G, Leendertz FH. 2012. Drug-resistant human Staphylococcus aureus in sanctuary apes pose a threat to endangered wild ape populations. Am J Primatol 74:1071-1075. http://dx.doi.org/10.1002/ajp. 22067.
14. Schaumburg F, Peters G, Alabi A, Becker K, Idelevich EA. 2016. Missense mutations of PBP2a are associated with reduced susceptibility to ceftaroline and ceftobiprole in African MRSA. J Antimicrob Chemother 71:41-44. http://dx.doi.org/10.1093/jac/dkv325.